Phase II Study of High-Dose [(131)I]Metaiodobenzylguanidine Therapy for Patients With Metastatic Pheochromocytoma and Paraganglioma

PURPOSE: To evaluate the safety and efficacy of high-dose [(131)I]metaiodobenzylguanidine ([(131)I]MIBG) in the treatment of malignant pheochromocytoma (PHEO) and paraganglioma (PGL). METHODS: Fifty patients with metastatic PHEO or PGL, age 10 to 64 years, were treated with [(131)I]MIBG doses rangin...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Gonias, Sara, Goldsby, Robert, Matthay, Katherine K., Hawkins, Randall, Price, David, Huberty, John, Damon, Lloyd, Linker, Charles, Sznewajs, Aimee, Shiboski, Steve, Fitzgerald, Paul
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2009
Assuntos:
Original Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2734428/
https://ncbi.nlm.nih.gov/pubmed/19636009
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.21.3496
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares